Sign in

CIK 0001821825

  • Large accelerated filer

Organon & Co.

Sign in to watch
Ticker
OGN
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
464838035
Phone
+1 551-430-6000
Business address
30 HUDSON STREET, FL 33, JERSEY CITY, NJ, 07302
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 84 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-31 Nisita Vittorio Head of Global Business Svcs Grant or award +2,862 9,967
2023-03-31 Nisita Vittorio Head of Global Business Svcs Shares withheld for taxes −981 $23.09 $23K 8,986
2023-03-31 Nisita Vittorio Head of Global Business Svcs Option exercise · Restricted Stock Units −2,862 5,726
2023-03-31 Nisita Vittorio Head of Global Business Svcs Grant or award · Stock Option (right to buy) +49,618 49,618
2023-03-31 Morrissey Joseph T. Jr. Head of Manufacturing Option exercise +3,936 18,636
2023-03-31 Morrissey Joseph T. Jr. Head of Manufacturing Shares withheld for taxes −1,122 $23.09 $26K 17,514
2023-03-31 Morrissey Joseph T. Jr. Head of Manufacturing Option exercise · Restricted Stock Units −3,936 7,873
2023-03-31 Morrissey Joseph T. Jr. Head of Manufacturing Grant or award · Restricted Stock Units +23,384 23,384
2023-03-31 Morrissey Joseph T. Jr. Head of Manufacturing Grant or award · Stock Option (right to buy) +83,969 83,969
2023-03-31 Milligan Sandra Head of Research & Development Option exercise +5,964 26,825
2023-03-31 Milligan Sandra Head of Research & Development Shares withheld for taxes −2,115 $23.09 $49K 24,710
2023-03-31 Milligan Sandra Head of Research & Development Option exercise · Restricted Stock Units −5,964 11,928
2023-03-31 Milligan Sandra Head of Research & Development Grant or award · Restricted Stock Units +29,230 29,230
2023-03-31 Milligan Sandra Head of Research & Development Grant or award · Stock Option (right to buy) +104,961 104,961
2023-03-31 Fiedler Susanne Chief Commercial Officer Option exercise +4,771 22,166
2023-03-31 Fiedler Susanne Chief Commercial Officer Shares withheld for taxes −1,520 $23.09 $35K 20,646
2023-03-31 Fiedler Susanne Chief Commercial Officer Option exercise · Restricted Stock Units −4,771 9,543
2023-03-31 Fiedler Susanne Chief Commercial Officer Grant or award · Restricted Stock Units +23,384 23,384
2023-03-31 Fiedler Susanne Chief Commercial Officer Grant or award · Stock Option (right to buy) +83,969 83,969
2023-03-31 Falcione Aaron Chief Human Resources Officer Option exercise +3,578 13,365

Page 30 of 33 · 650 trades